VRXA Veraxa Biotech AG

P/E --
Forward P/E --
Price/Sales 7605.82
Beta 0.192
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ Veraxa Biotech is trading 5% down; no clear catalyst identified

Veraxa Biotech is trading lower at $1.24, down 5.34%, on September 30, 2026, with no clear company-specific catalyst identified. - The event calendar lists a...

πŸ”΄ Veraxa Biotech is trading 5% down with no clear catalyst identified

Veraxa Biotech is trading 5.1% lower at $1.30 on September 29, 2026, with no clear company-specific catalyst identified. - Shares closed at $1.37 on September...

🟒 Veraxa Biotech is trading 6.38% up in pre-market amid broader biotech strength

Veraxa Biotech is trading 6.38% higher at $1.50 in pre-market following broader biotechnology strength; no company-specific catalyst was identified. - Shares...

🟒 Veraxa Biotech is trading 6.5% up in pre-market amid broader biotech momentum

Veraxa Biotech is trading 6.5% up in pre-market at $1.48, versus the September 23 close of $1.39, amid broader biotech momentum on September 24, 2026. - XBI...

🟒 Veraxa Biotech is trading 11.35% up in pre-market on biotech-sector strength

Veraxa Biotech is trading at $1.57, up 11.35%, with biotech-sector strength providing the strongest explanation. - No fresh company-specific announcement or...

🟒 Veraxa Biotech is trading 5.63% up in pre-market β€” no fresh catalyst identified

Veraxa Biotech is trading 5.63% up at $1.50 after rising from the September 21 close of $1.42; no fresh company-specific catalyst dated September 22, 2026 was...

🟒 Veraxa Biotech is trading 7.89% up in pre-market with no clear catalyst identified

Veraxa Biotech is trading 7.89% up at $1.64 in pre-market; no new company-specific announcement was identified for September 16, 2026, and the immediate reason...

πŸ”΄ Veraxa Biotech is trading 5.52% down today amid biotech-sector pressure after disappointing drug-trial news elsewhere

Veraxa Biotech is trading 5.52% down at $1.54, with biotechnology weakness and broad risk-off conditions the most likely immediate drivers. - No...

🟒 Veraxa Biotech is trading 5.65% up today; catalyst remains unclear

Veraxa Biotech is trading 5.65% up at $1.68, though the catalyst remains unclear. - No clear company-specific announcement dated September 10, 2026, was...

πŸ”΄ Veraxa Biotech is trading 10.23% down today after likely profit-taking

Veraxa Biotech is trading at $1.58, down 10.23%, as likely profit-taking follows its sharp multi-session advance. - Shares rose 15.03% to $1.76 on September 4...

πŸ”΄ Veraxa Biotech is trading 6.25% down today amid likely profit-taking

Veraxa Biotech is trading 6.25% down at $1.65, pressured by softer broader-market sentiment and likely profit-taking after a sharp multi-session rally. -...

πŸ”΄ Veraxa Biotech is trading 5.9% down in pre-market following a sharp rally during prior sessions

Veraxa Biotech is trading at $1.66 (-5.93%) after a sharp rally during prior sessions. - The stock declined from the $1.76 September 7 close. - No new...

🟒 Veraxa Biotech is trading 13.07% up today after appointing Raju Willener as CFO

Veraxa Biotech is trading 13.07% up at $1.73 after appointing Raju Willener as chief financial officer, effective September 4, 2026. - He succeeds Carl von...

Veraxa Biotech Swaps CFOs and Stock Jumps 23% in a Week β€” Can a New Finance Chief Revive a Sub-$2 Stock?

Veraxa Biotech Swaps CFOs and Stock Jumps 23% in a Week β€” Can a New Finance Chief Revive a Sub-$2 Stock?

Shares of Veraxa Biotech AG shifted sharply upward as the Swiss clinical-stage biotech installed Raju Willener as its new Chief Financial Officer, effective...

🟒 Veraxa Biotech is trading 8.5% up today after immediate appointment of Raju Willener as CFO

Veraxa Biotech is trading 8.5% up at $1.66 after announcing Raju Willener’s immediate CFO appointment on September 4, 2026. - Willener brings more than 30...

🟒 Veraxa Biotech is trading 12.3% up today as XBI gains 2.75%

Veraxa Biotech is trading at $1.55, up 12.32%, amid stronger biotech sector sentiment rather than a confirmed company-specific catalyst. - XBI is up 2.75%,...

🟒 Veraxa Biotech is trading 5.4% up today amid patent-related enthusiasm

Veraxa Biotech is trading at $1.46, up +5.43% on September 3, 2026, amid patent-related enthusiasm and improving biotechnology sentiment. - The biotech sector...

🟒 Veraxa Biotech is trading 14.27% up today β€” isolated rebound without a clear catalyst

Veraxa Biotech is trading 14.27% up now at $1.54, rebounding after several consecutive declines. - Shares fell from $1.95 on August 21, 2026, to $1.35 on...

🟒 Veraxa Biotech is trading 8.89% up today after several consecutive declines

Veraxa Biotech is trading 8.89% up at $1.47, following several consecutive declines. - Closing price fell from $1.95 to $1.35 between August 21–31. - No clear...

πŸ”΄ Veraxa Biotech is trading 5.56% down today β€” no company-specific catalyst identified

Veraxa Biotech is trading 5.56% down now at $1.36 after extending declines from its August 27, 2026 close of $1.44; no credible company-specific announcement...